Eversept Partners, LP Assembly Biosciences, Inc. Transaction History

Eversept Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.35 - $2.29 $378,000 - $641,200	-280,000 Closed	0 $0
Q1 2022 Nov 08, 2023	BUY	$1.46 - $2.45 $408,800 - $686,000	280,000 New	280,000 $576,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $43,800 - $73,500	-30,000 Reduced 9.68%	280,000 $577,000
Q4 2021 Nov 08, 2023	SELL	$2.13 - $3.46 $85,200 - $138,400	-40,000 Reduced 11.43%	310,000 $722,000
Q4 2021 Feb 14, 2022	SELL	$2.13 - $3.46 $85,200 - $138,400	-40,000 Reduced 11.43%	310,000 $722,000
Q3 2021 Nov 08, 2023	BUY	$3.14 - $3.9 $1.1 Million - $1.37 Million	350,000 New	350,000 $1.22 Million
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $1.1 Million - $1.37 Million	350,000 New	350,000 $1.22 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.